Clinical data analysis indicated that low expression of FCN3 was significantly correlated with AFP, tumor size, number of tumors, microvascular invasion and Edmondson-Steiner classification in 202 patients of HCC (Table 1). This evidence concerns the gene FCN3 and hepatocellular carcinoma.